This is a publication of the rendered service to healthcare professionals and healthcare organizations:
Collaboration between the pharmaceutical industry, healthcare professionals and healthcare organizations brings benefits to patients. This collaboration has brought a number of innovative medicines and has changed the course of treatment for many diseases. Our joint work involves a range of activities ranging from clinical research to the sharing of best curative procedures. As a compensation for the time that experts and organizations do to work for our company, we provide them with reasonable payments.
On June 30, 2016, Novartis across Europe announced for the first time financial performance that was provided to healthcare professionals and healthcare organizations in accordance with the Disclosure Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA). In the Czech Republic, in accordance with the transparent cooperation of the Association of Innovative Pharmaceutical Industry (AIFP). Novartis is doing everything to support the decision of health professionals to agree to the individual disclosure of the benefits received.
Transparent cooperation helps clarify the scope and nature of cooperation between healthcare professionals, healthcare organizations and pharmaceutical companies. We are convinced that open payment communication helps to strengthen the trust of patients, professionals, public administration and the public. In addition, it demonstrates our commitment to adhering to strict ethical business standards.
Novartis Pharma transparent cooperation
Novartis Pharma Disclosure Report AIFP
Novartis Pharma Methodological Note MN Novartis (PDF 0.3 MB)
Contact: [email protected]
Helpful links
Association of Innovative Pharmaceutical Industry (AIFP) AIFP
European Federation of Pharmaceutical Industries and Associations (EFPIA) EFPIA
Healthcare Professional Payment Transparency Payments to Healthcare Professionals | Novartis